期刊文献+
共找到15篇文章
< 1 >
每页显示 20 50 100
Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy
1
作者 Xiaoju Guo Xiaoxiao chen +11 位作者 Jiayi Ding Feng Zhang Shunyang chen Xin Hu Shiji Fang Lin Shen chenying Lu Zhongwei Zhao Jianfei Tu Gaofeng Shu minjiang chen Jiansong Ji 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2024年第2期136-152,共17页
Chemotherapy plays a crucial role in triple-negative breast cancer (TNBC) treatment as it not only directly kills cancer cells but also induces immunogenic cell death. However, the chemotherapeutic efficacy was strong... Chemotherapy plays a crucial role in triple-negative breast cancer (TNBC) treatment as it not only directly kills cancer cells but also induces immunogenic cell death. However, the chemotherapeutic efficacy was strongly restricted by the acidic and hypoxic tumor environment. Herein, we have successfully formulated PLGA-based nanoparticles concurrently loaded with doxorubicin (DOX), hemoglobin (Hb) and CaCO3 by a CaCO3-assisted emulsion method, aiming at the effective treatment of TNBC. We found that the obtained nanomedicine (DHCaNPs) exhibited effective drug encapsulation and pH-responsive drug release behavior. Moreover, DHCaNPs demonstrated robust capabilities in neutralizing protons and oxygen transport. Consequently, DHCaNPs could not only serve as oxygen nanoshuttles to attenuate tumor hypoxia but also neutralize the acidic tumor microenvironment (TME) by depleting lactic acid, thereby effectively overcoming the resistance to chemotherapy. Furthermore, DHCaNPs demonstrated a notable ability to enhance antitumor immune responses by increasing the frequency of tumor-infiltrating effector lymphocytes and reducing the frequency of various immune-suppressive cells, therefore exhibiting a superior efficacy in suppressing tumor growth and metastasis when combined with anti-PD-L1 (αPD-L1) immunotherapy. In summary, this study highlights that DHCaNPs could effectively attenuate the acidic and hypoxic TME, offering a promising strategy to figure out an enhanced chemo-immunotherapy to benefit TNBC patients. 展开更多
关键词 CaCO3-based nanoparticles Hypoxia attenuation Acidity neutralization Reversal of chemotherapy resistance Enhanced chemo-immunotherapy
下载PDF
晚期肺炎型肺癌:一项中国单中心临床-放射-病理特征回顾性研究及预后分析 被引量:27
2
作者 留永健 李霁 +6 位作者 王世波 陈闽江 赵静 蒋德利娜 钟巍 徐燕 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2019年第6期329-335,共7页
背景与目的肺炎型肺癌是一种临床和影像表现特殊的肺癌。本研究旨在总结此类肺癌的临床、影像及病理学特征,诊断手段,治疗方案及预后情况。方法肺炎型肺癌定义为:肺部计算机断层扫描(computed tomography, CT)以磨玻璃或实变影为主要表... 背景与目的肺炎型肺癌是一种临床和影像表现特殊的肺癌。本研究旨在总结此类肺癌的临床、影像及病理学特征,诊断手段,治疗方案及预后情况。方法肺炎型肺癌定义为:肺部计算机断层扫描(computed tomography, CT)以磨玻璃或实变影为主要表现,经组织学或细胞学明确诊断的肺癌。收集2013年1月1日-2018年8月30日期间,就诊于北京协和医院呼吸与危重症医学科的晚期肺炎型肺癌病例,回顾性分析这些患者临床资料并进行生存随访。结果共纳入46例患者,均为肺腺癌。咳嗽(41/46, 89.1%)、咳痰(35/46, 76.1%)是最常见的临床表现。胸部CT常见表现为磨玻璃影(87.0%)、实变影(84.8%)、以及多发磨玻璃结节(84.8%),多发囊样变和空洞分别为40.0%和13.0%。同侧及对侧肺转移分别见于95.3%和84.8%的病例。从出现症状到明确诊断的中位时间为214天(95%CI:129-298)。CT引导肺穿刺活检及外科肺活检的确诊率为100%,支气管镜下的支气管肺泡灌洗(BAL)联合经支气管肺活检(TBLB)的确诊率为80.9%(17/21),痰液病理学检查的确诊率为45.0%(9/20)。病理亚型,26例(26/46, 56.5%)为浸润性粘液腺癌,20例患者因缺乏足够的病理标本量而无法进一步区分亚型。38例进行了EGFR基因检测,6例(6/38, 15.8%)有突变。33例进行ALK基因检测,仅1例(1/33, 3.0%)有ALK重排。中位总生存期(overall survival, OS)为522天(95%CI:424-619)。EGFR野生型或ALK融合基因阴性的患者,化疗明显延长中位OS(HR=0.155, P=0.002,2),接受化疗者中位OS 547天(95%CI:492-602),不接受化疗者中位OS 331天(95%CI:22-919)。结论肺炎型肺癌由于其临床和影像特征与肺部感染相似而经常导致延误诊断。支气管镜下的BAL联合TBLB有相当高的确诊率。浸润性粘液腺癌为肺炎型肺癌的主要病理亚型。肺炎型肺癌EGFR突变及ALK重排发生率很低。对于无明确驱动基因的患者,应积极行化疗,延长患者生存期。 展开更多
关键词 肺肿瘤 肺炎型肺癌 浸润性肺粘液腺癌
下载PDF
132例晚期非小细胞肺癌胸腔积液EGFR基因突变检测结果及其临床意义:一项来自单中心的回顾性研究 被引量:12
3
作者 鲁涛 李强 +9 位作者 李岚 杨凯珍 周丹菲 高洁 陈闽江 徐燕 钟巍 王孟昭 梁智勇 赵静 《中国肺癌杂志》 CAS CSCD 北大核心 2020年第12期1059-1065,共7页
背景与目的恶性胸腔积液表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变检测缺乏病理质控,导致对检测结果解释及指导临床EGFR酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)使用造成困惑。因此,提出质控标准,并... 背景与目的恶性胸腔积液表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变检测缺乏病理质控,导致对检测结果解释及指导临床EGFR酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)使用造成困惑。因此,提出质控标准,并按此标准进行胸水EGFR突变检测尤为重要。本研究拟回顾性分析按照严格病理质控标准进行的胸水沉渣切片EGFR基因突变检测结果以及据此结果指导EGFR-TKIs治疗的疗效。方法回顾性分析中国医学科学院北京协和医院病理科2012年1月-2018年6月收到的胸腔积液标本的患者临床资料,其中具有临床资料相对完整,且按照制定的质控标准进行了胸水沉渣石蜡包埋切片EGFR基因突变检测的患者132例。根据EGFR基因突变检测结果,分为阳性组和阴性组,比较不同组别使用EGFR-TKIs的疗效。结果胸腔积液经离心后,沉渣石蜡包埋、切片,HE染色后镜下观察,若肿瘤细胞数目≥100个,即满足病理质控标准,可用于后续EGFR基因突变检测。132例患者中,72例(54.5%)患者胸水中检出EGFR基因突变。72例突变阳性患者中,69例患者使用了EGFR-TKIs。60例EGFR突变阴性患者中,仅15例使用EGFR-TKIs。EGFR突变阳性组的疾病控制率(disease control rate,DCR)为95.8%,中位无疾病进展生存时间(progression-free survival,PFS)为11个月;EGFR突变阴性组的DCR为0%,中位PFS为1个月,两组患者DCR和PFS均有显著差异(P<0.05)。结论经病理质控的胸水沉渣包埋切片可用于EGFR基因突变检测,其结果可指导临床EGFR-TKIs使用。 展开更多
关键词 肺肿瘤 胸腔积液 表皮生长因子受体突变 治疗 病理质控
下载PDF
术前恶性不除外手术病理确诊肺部良性病变297例患者临床-放射-病理特征分析:一项中国单中心回顾性队列研究 被引量:13
4
作者 留永健 陈闽江 +13 位作者 郭超 钟巍 叶秋月 赵静 周晴 高晓星 刘潇衍 梁红格 石岳泉 蒋德利娜 刘洪生 徐燕 李单青 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2020年第9期792-799,共8页
背景与目的随着癌症早筛意识的提高,低剂量计算机断层扫描(low-dose computed tomography,LDCT)用于肺癌筛查在中国广泛开展。尽管有部分胸部LDCT筛查所见的肺部病灶是肿瘤病灶,但大多数的肺部结节是良性病变。如何有效的对肺部病灶进... 背景与目的随着癌症早筛意识的提高,低剂量计算机断层扫描(low-dose computed tomography,LDCT)用于肺癌筛查在中国广泛开展。尽管有部分胸部LDCT筛查所见的肺部病灶是肿瘤病灶,但大多数的肺部结节是良性病变。如何有效的对肺部病灶进行术前鉴别,如何降低部分可避免手术的良性疾病的手术切除比例,是需要关注的问题。方法本研究纳入2017年1月1日-2018年12月31日期间北京协和医院诊治的,术前考虑肺部恶性病变不能除外,经手术病理确认为良性病变的患者,回顾性分析患者临床信息。结果 297例患者纳入本研究,占我院肺部病灶行肺部手术治疗患者的9.8%。197例(66.3%)患者因体检行LDCT筛查发现肺部病灶。肺部病变胸部CT影像学评估情况,可评估的323个病灶,平均长径为(17.9±12.1)mm,直径≥8 mm的占91.0%,实性最多见(212/323, 65.6%),此类肺部病灶可有毛刺征(71/323, 22.0%)、分叶征(94/323, 29.1%)、胸膜牵拉征(81/323, 25.1%)、血管集束征(130/323, 40.2%)、空泡征(23/323, 7.1%)等,提示恶性病变的影像学特征。292例(98.3%)行电视辅助胸腔镜手术(video-assisted thoracoscopic surgery, VATS),232例(78.1%)患者行肺楔形切除术,13例(4.4%)行肺段切除术,51例(17.2%)患者行肺叶切除术。4例(1.3%)患者出现手术并发症。术后病理类型前3位的是感染性疾病98例(33.0%)、炎性结节96例(32.3%)和错构瘤64例(21.5%)。结论因术前不能排除恶性而行手术切除的肺部良性病灶,影像学表现以实性病灶多见,但多具有提示恶性的影像学特征。VATS可作为一种明确病原病理的重要活检方式。此类病灶病理结果以感染性疾病和炎性结节最为常见,错构瘤第三。 展开更多
关键词 肺部良性病变 肺结节 肺肿瘤 肺癌筛查
下载PDF
表皮生长因子酪氨酸激酶抑制剂一线治疗突变阳性晚期非小细胞肺癌的临床疗效预测因素分析 被引量:9
5
作者 陈闽江 徐燕 +2 位作者 赵静 钟巍 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2019年第2期99-104,共6页
背景与目的一线应用表皮生长因子-酪氨酸激酶抑制剂(epidermal growth factor receptor tyrosine kinase inhibitors, EGFR-TKIs)治疗具有EGFR基因突变的晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)疗效显著,但患者的无进展... 背景与目的一线应用表皮生长因子-酪氨酸激酶抑制剂(epidermal growth factor receptor tyrosine kinase inhibitors, EGFR-TKIs)治疗具有EGFR基因突变的晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)疗效显著,但患者的无进展生存时间(progression free survival, PFS)可有较大差异。既往研究表明一些临床因素可能与疗效相关,本研究旨在探讨影响EGFR-TKI疗效的临床预测因素。方法收集203例存在EGFR基因敏感突变且一线接受EGFRTKI治疗的晚期NSCLC患者的人口学及临床资料并进行回顾性分析。结果截至随访结束时203例患者中共有139例发生病情进展,63例死亡。中位随访时间为21.1个月,中位PFS为14.3个月。接受治疗患者疾病部分缓解(partial response, PR)127例(66.1%),疾病稳定(stable disease, SD)55例(28.6%)。与PFS相关的单因素分析结果显示,ECOG评分≥2分(5.1个月vs 16个月,P=0.033)、最佳疗效为SD(9.5个月vs 17.9个月,P=0.030)、合并胸腔外远处转移(11.7个月vs 27.5个月,P=0.004)、肝转移(4.1个月vs 16.0个月,P=0.000)、骨转移(13.3个月vs 21.5个月,P=0.027)和同时并发肺栓塞(5.5个月vs 16.6个月,P=0.005)的患者PFS明显缩短。多因素Cox回归结果显示合并肝转移(HR=1.694, 95%CI:1.146-5.756, P=0.022)、最佳治疗反应仅达到SD(HR=1.825, 95%CI:1.107-3.008, P=0.018)是独立的疗效预测因素。结论对于EGFR突变阳性的晚期NSCLC患者,一线应用EGFR-TKI治疗效果良好。治疗的最佳疗效以及基线肝转移是PFS的独立临床预测因素。 展开更多
关键词 肺肿瘤 预测因素 表皮生长因子受体酪氨酸激酶抑制剂
下载PDF
临床疑诊肺癌纵隔淋巴结转移EBUS-TBNA阴性患者的处理 被引量:7
6
作者 留永健 陈闽江 +6 位作者 孙雪峰 邵池 徐燕 陈勇 赵媛媛 赵静 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2019年第4期223-227,共5页
背景与目的超声气管镜针吸活检(endobronchial ultrasound guided tranbronchial needle aspiration, EBUSTBNA)是肺癌诊断和分期的重要手段,但经活检阴性结果的患者后续处理尚无标准流程。本文通过分析来自单中心的临床疑诊肺癌纵隔淋... 背景与目的超声气管镜针吸活检(endobronchial ultrasound guided tranbronchial needle aspiration, EBUSTBNA)是肺癌诊断和分期的重要手段,但经活检阴性结果的患者后续处理尚无标准流程。本文通过分析来自单中心的临床疑诊肺癌纵隔淋巴结转移但EBUS-TBNA病理结果阴性患者,以探讨此类患者处理方式。方法对北京协和医院2010年9月-2016年12月进行EBUS-TBNA的1,412例患者资料进行分析,选取临床疑诊肺癌纵隔淋巴结转移但EBUS-TBNA病理诊断阴性的患者51例进行回顾性分析。结果入选51例患者按临床情况和后续处理方式分为以下5组:(1)经同一次气管镜下其他检查组(9例):该组患者大多(8例)存在镜下异常表现,通过活检、毛刷、灌洗或经支气管镜肺活检(transbronchial lung biopsy, TBLB)取得明确诊断;(2)再次EBUS-TBNA组(11例):该组患者气管粘膜及管腔大致正常,再次行EBUS-TBNA取得诊断;(3)手术治疗组(6例):该组患者因EBUS结果除外纵隔淋巴结转移,接受手术治疗。其中5例术后确诊无淋巴结转移癌;(4)进行其他病理检查组(15例):该组患者有其他部位转移,针对可能的转移灶进行计算机断层扫描(computed tomography, CT)引导下穿刺、淋巴结活检等确诊。(5)随访组(10例):该组患者未进行其他有创检查,中位随访时间38个月,其中1例随访中诊断为淋巴瘤。结论对于经EBUS-TBNA未能确定诊断而临床怀疑肺癌的患者,应该根据患者的具体情况,综合多种方式进行诊断。对于暂时无法确诊的患者,仍需要长期随访。 展开更多
关键词 超声内镜引导下的经支气管针吸活检 病理阴性 肺肿瘤
下载PDF
肺癌伴胰腺转移42例临床分析 被引量:7
7
作者 张宇 陈闽江 +3 位作者 赵静 钟巍 徐燕 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2019年第4期228-232,共5页
背景与目的多数肺癌患者在诊断时即出现远处转移,常见的转移部位包括肝脏、脑等,其中胰腺转移较为罕见。胰腺转移起病隐匿,预后普遍较差。目前医生对其的认识程度和重视程度不足。本研究旨在分析肺癌胰腺转移患者的病理特征、临床表现... 背景与目的多数肺癌患者在诊断时即出现远处转移,常见的转移部位包括肝脏、脑等,其中胰腺转移较为罕见。胰腺转移起病隐匿,预后普遍较差。目前医生对其的认识程度和重视程度不足。本研究旨在分析肺癌胰腺转移患者的病理特征、临床表现、治疗方案、预后以及相关因素对生存期的影响,探讨延长肺癌伴胰腺转移患者生存期及改善其生活质量的最佳治疗方案。方法回顾性分析自1998年1月-2018年12月于北京协和医院就诊的42例信息资料完整的肺癌胰腺转移患者。结果 24例患者(57%)无特异性胰腺转移症状,18例患者(43%)出现胰腺转移相关症状,表现为腰背痛、急性胰腺炎、梗阻性黄疸。中位总生存期(overall survival, OS)为8.8个月。经多因素分析,存在急性胰腺炎等症状的患者预后偏差[危险比(hazard ratio, HR)=2.645,95%CI:1.013-6.910,P=0.047]。胰腺转移后接受化疗的患者预后明显优于未接受化疗治疗的患者[HR=0.158, 95%CI:0.049-0.512, P=0.002]。结论肺癌胰腺转移罕见,预后差,存在胰腺相关症状者相对更差。接受化疗治疗能明显延长患者生存期。胰腺的局部放疗治疗可以缓解局部症状,利于患者进一步接受化疗治疗。有胰腺转移灶症状的患者可从化疗联合胰腺局部放疗的综合治疗中受益。 展开更多
关键词 肺肿瘤 胰腺转移 急性胰腺炎 梗阻性黄疸 化疗治疗 局部放疗
下载PDF
超声气管镜针吸活检在肺癌诊断及基因检测中的作用 被引量:3
8
作者 陈闽江 邵池 +6 位作者 徐燕 孙雪峰 赵静 陈勇 赵媛媛 钟巍 王孟昭 《中国肺癌杂志》 CAS CSCD 北大核心 2018年第9期670-676,共7页
背景与目的超声气管镜针吸活检(endobronchial ultrasound guided tranbronchial needle aspiration, EBUSTBNA)是临床怀疑肺癌患者的常用活检方式,在肺癌的诊断和分期中有着举足轻重的作用。然而该活检方式在诊断之余是否亦能提供充分... 背景与目的超声气管镜针吸活检(endobronchial ultrasound guided tranbronchial needle aspiration, EBUSTBNA)是临床怀疑肺癌患者的常用活检方式,在肺癌的诊断和分期中有着举足轻重的作用。然而该活检方式在诊断之余是否亦能提供充分的组织完成基因检测尚待研究。本文评价EBUS-TBNA所取得标本进行肺癌诊断及相关基因检测的可行性。方法对纵隔淋巴结肿大且临床怀疑肺癌诊断的患者进行EBUS-TBNA活检,所取得的标本进行病理诊断并对其中的非鳞非小细胞肺癌标本进行驱动基因检测。分析其诊断阳性率以及完成基因检测的可行性。结果入选377例患者平均单个淋巴结穿刺2.07针,确诊肺癌213例,经EBUS-TBNA诊断率92%。其中表皮生长因子受体(epidermal growth factor receptor, EGFR)基因、间变淋巴瘤激酶(anaplasticlymphoma kinase, ALK)融合基因、以及同时完成两个基因检测的患者分别为84例(90%)、105例(96%)及79例(90%)。单因素分析显示组织基因检测成功率与穿刺淋巴结针数、淋巴结大小及淋巴结部位无关,但与肿瘤病理类型相关。腺癌病理类型的EGFR基因突变及ALK融合基因检测的成功率均高于未分类非小细胞肺癌。结论 EBUS-TBNA可提供充足的组织对肺癌进行诊断和基因分型。肿瘤病理类型可能是影响基因检测阳性率的因素。 展开更多
关键词 超声气管镜针吸活检 肺肿瘤 基因检测
下载PDF
Precision interventional radiology 被引量:1
9
作者 Jiansong Ji Shiji Fang +4 位作者 minjiang chen Liyun zheng Weiqian chen Zhongwei Zhao Yongde cheng 《Journal of Interventional Medicine》 2021年第4期155-158,共4页
The recent interest in precision medicine among interventionists has led to the establishment of the concept of precision interventional radiology(PIR).This concept focuses not only on the accuracy of interventional o... The recent interest in precision medicine among interventionists has led to the establishment of the concept of precision interventional radiology(PIR).This concept focuses not only on the accuracy of interventional operations using traditional image-guided techniques,but also on the comprehensive evaluation of diseases.The invisible features extracted from CT,MRI,or US improve the accuracy and specificity of diagnosis.The integration of multi-omics and molecule imaging provides more information for interventional operations.The development and application of drugs,embolic materials,and devices broaden the concept of PIR.Integrating medicine and engineering brings new image-guided techniques that increase the efficacy of interventional operations while reducing the complications of interventional treatment.In all,PIR,an important part of precision medicine,emphasizing the whole disease management process,including precision diagnosis,comprehensive evaluation,and interventional therapy,maximizes the benefits of patients with limited damage. 展开更多
关键词 Precision interventional radiology Anatomical location Comprehensive evaluation Interventional therapy Precision diagnosis
下载PDF
Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery
10
作者 Gaofeng Shu Lin Shen +10 位作者 Jiayi Ding Junchao Yu Xiaoxiao chen Xiaoju Guo Enqi Qiao Yaning chen chenying Lu Zhongwei Zhao Yongzhong Du minjiang chen Jiansong Ji 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2022年第6期908-923,共16页
The development of novel theranostic agents with outstanding diagnostic and therapeutic performances is still strongly desired in the treatment of hepatocellular carcinoma(HCC).Here,a fucoidan-modified mesoporous poly... The development of novel theranostic agents with outstanding diagnostic and therapeutic performances is still strongly desired in the treatment of hepatocellular carcinoma(HCC).Here,a fucoidan-modified mesoporous polydopamine nanoparticle dual-loaded with gadolinium iron and doxorubicin(FMPDA/Gd^(3+)/DOX)was prepared as an effective theranostic agent for magnetic resonance imaging(MRI)-guided chemo-photothermal therapy of HCC.It was found that FMPDA/Gd^(3+)/DOX had a high photothermal conversion efficiency of 33.4%and excellent T1-MRI performance with a longitudinal relaxivity(r1)value of 14.966 m M^(-1)·s^(-1).Moreover,the results suggested that FMPDA/Gd^(3+)/DOX could effectively accumulate into the tumor foci by dual-targeting the tumor-infiltrated platelets and HCC cells,which resulted from the specific interaction between fucoidan and overexpressed p-selectin receptors.The excellent tumor-homing ability and MRI-guided chemo-photothermal therapy therefore endowed FMPDA/Gd^(3+)/DOX with a strongest ability to inhibit tumor growth than the respective single treatment modality.Overall,our study demonstrated that FMPDA/Gd^(3+)/DOX could be applied as a potential nanoplatform for safe and effective cancer theranostics. 展开更多
关键词 Mesoporous polydopamine FUCOIDAN P-selectin target Platelets bridge Cancer theranostics
下载PDF
^(125)I放射性粒子条联合胆道支架与单纯胆道支架植入治疗恶性胆道梗阻的术后院内感染发生率及临床疗效的对照研究
11
作者 陈丽 陈敏江 +3 位作者 任建敏 谢艳茹 涂建飞 纪建松 《中华介入放射学电子杂志》 2024年第2期144-149,共6页
目的回顾性研究联合组[^(125)I(iodine)粒子条+胆道支架]及常规组(单纯胆道支架组)治疗恶性胆道梗阻(malignant biliary obstruction,MBO)的术后院内感染发生率及临床疗效。方法收集2019年4月至2022年6月期间因MBO就诊于温州医科大学附... 目的回顾性研究联合组[^(125)I(iodine)粒子条+胆道支架]及常规组(单纯胆道支架组)治疗恶性胆道梗阻(malignant biliary obstruction,MBO)的术后院内感染发生率及临床疗效。方法收集2019年4月至2022年6月期间因MBO就诊于温州医科大学附属第五医院(丽水市中心医院)且经皮肝穿刺胆道引流术(percutaneous transhepatic cholangial drainage,PTCD)序贯行胆道支架植入的128例(联合组70例、常规组58例)MBO患者的临床资料,所有病例PTCD术中获取胆汁,术后监测相关指标及不良事件情况,分析2组的术后院内感染发生率、术后总胆红素下降速率、支架通畅时间、不良事件发生率等。结果2组术后院内感染发生率比较,差异无统计学意义(8.5%∶8.6%;P>0.05);WBC(blood cell count)计数>10×10^(9)/L者较WBC计数≤10×10^(9)/L者,PTCD术中胆汁阳性率相对更高(48%∶26.2%;P<0.05);本研究共39例患者胆汁培养阳性,病原体构成比居前3位分别为肺炎克雷伯菌13例(32%)、大肠杆菌9例(22%)、铜绿假单胞菌7例(18%)。联合组术后总胆红素下降速率相对更快(7.1 d∶11.2 d;P<0.05);联合组及常规组的胆道支架中位通畅时间分别为5.9个月(95%CI:5~7个月)、2.6个月(95%CI:2~4个月),差异有统计学意义(P<0.05)。结论联合组未增加术后院内感染发生率,且临床疗效优于常规组,安全性高;PTCD术前WBC计数>10×109/L者胆汁阳性率更高,该类患者建议及早使用抗生素;胆道常见病原体前3位分别为肺炎克雷伯菌、大肠杆菌、铜绿假单胞菌。 展开更多
关键词 院内感染 胆道感染 胆道梗阻 胆道支架
原文传递
Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer 被引量:6
12
作者 Gaofeng Shu minjiang chen +13 位作者 Jingjing Song Xiaoling Xu chenying Lu Yuyin Du Min Xu Zhongwei Zhao Minxia Zhu Kai Fan Xiaoxi Fan Shiji Fang Bufu Tang Yiyang Dai Yongzhong Du Jiansong Ji 《Bioactive Materials》 SCIE 2021年第5期1423-1435,共13页
diagnostic and therapeutic capability are highly needed for the treatment of hepatic cancer.Herein,we aimed to develop a novel mesoporous polydopamine(MPDA)-based theranostic agent for T1/T2 dual magnetic resonance im... diagnostic and therapeutic capability are highly needed for the treatment of hepatic cancer.Herein,we aimed to develop a novel mesoporous polydopamine(MPDA)-based theranostic agent for T1/T2 dual magnetic resonance imaging(MRI)-guided cancer chemo-photothermal therapy.Superparamagnetic iron oxide(SPIO)-loaded MPDA NPs(MPDA@SPIO)was firstly prepared,followed by modifying with a targeted molecule of sialic acid(SA)and chelating with Fe^(3+)(SA-MPDA@SPIO/Fe^(3+) NPs).After that,doxorubicin(DOX)-loaded SA-MPDA@SPIO/Fe^(3+) NPs(SA-MPDA@SPIO/DOX/Fe^(3+))was prepared for tumor theranostics.The prepared SAPEG-MPDA@SPIO/Fe^(3+) NPs were water-dispersible and biocompatible as evidenced by MTT assay.In vitro photothermal and relaxivity property suggested that the novel theranostic agent possessed excellent photothermal conversion capability and photostability,with relaxivity of being r1=4.29 mM1s1 and r2=105.53 mM1s1,respectively.SAPEG-MPDA@SPIO/Fe^(3+) NPs could effectively encapsulate the DOX,showing dual pH-and thermal-triggered drug release behavior.In vitro and in vivo studies revealed that SA-MPDA@SPIO/DOX/Fe^(3+) NPs could effectively target to the hepatic tumor tissue,which was possibly due to the specific interaction between SA and the overexpressed E-selectin.This behavior also endowed SA-MPDA@SPIO/DOX/Fe^(3+)NPs with a more precise T1-T2 dual mode contrast imaging effect than the one without SA modification.In addition,SAPEG-MPDA@SPIO/DOX/Fe^(3+) NPs displayed a superior therapeutic effect,which was due to its active targeting ability and combined effects of chemotherapy and photothermal therapy.These results demonstrated that SAPEG-MPDA@SPIO/DOX/Fe^(3+) NPs is an effective targeted nanoplatform for tumor theranostics,having potential value in the effective treatment of hepatic cancer. 展开更多
关键词 Hepatic cancer Mesoporous polydopamine Chemo-photothermal combined therapy T1/T2 dual-mode MRI Targeted delivery
原文传递
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor-associated myocarditis 被引量:4
13
作者 Yan Xu Yanjun Song +10 位作者 Xiaoyan Liu Yuequan Shi Yingxian Liu Hao Qian Xiaoxing Gao minjiang chen Ruili Pan Jing Zhao Wei Zhong Wei Wu Mengzhao Wang 《Cancer Communications》 SCIE 2022年第9期902-905,共4页
Dear Editor,The application of immune checkpoint inhibitors(ICIs),anti-tumor immunotherapy unleashing the host immune system to eradicate tumor cells,has revolutionized the treatment of various advanced cancers and sh... Dear Editor,The application of immune checkpoint inhibitors(ICIs),anti-tumor immunotherapy unleashing the host immune system to eradicate tumor cells,has revolutionized the treatment of various advanced cancers and showed remarkable anti-tumor effects[1].However,emphasis must be placed on fatal immune-related adverse events(irAEs),especially some fulminant irAEs like ICI-related cardiovascular AEs[2,3].However,due to the low rate of cardiovascular AEs,little is known about the effective methods for evaluating the risk of catastrophic cardiac events in ICI-associated myocarditis and its management[4,5]. 展开更多
关键词 CARDIAC MYOCARDITIS CARDIOVASCULAR
原文传递
Case report of neurofibromatosis type 1 combined with primary ciliary dyskinesia 被引量:2
14
作者 Chun Bian Xinyue Zhao +4 位作者 Yaping Liu minjiang chen Shuying Zheng Xinlun Tian Kai-Feng Xu 《Frontiers of Medicine》 SCIE CSCD 2021年第6期933-937,共5页
Neurofibromatosis(NF)is a genetic disease in which the lungs are rarely involved.However,in NF cases with lung involvement,chest computed tomography may show bilateral basal reticulations,apical bullae,and cysts witho... Neurofibromatosis(NF)is a genetic disease in which the lungs are rarely involved.However,in NF cases with lung involvement,chest computed tomography may show bilateral basal reticulations,apical bullae,and cysts without bronchiectasis.Herein,we report a patient diagnosed with NF on the basis of the results of genetic testing who presented with early-onset wet cough and bronchiectasis.Considering the differential diagnosis of bronchiectasis combined with his early-onset wet cough,sinusitis,and sperm quality decline,we considered the possibility of primary ciliary dyskinesia(PCD).Further electron microscopy analysis of cilia and identification of homozygous mutations in the RSPH4A gene confirmed the diagnosis of PCD.Therefore,for patients with NF,when an image change exists in the lungs that does not correspond to NF,the possibility of other diagnoses,including PCD,must be considered. 展开更多
关键词 primary ciliary dyskinesia NEUROFIBROMATOSIS BRONCHIECTASIS transmission electron microscopy genetic sequencing
原文传递
Thickness-dependent morphologies of Ag on n-layer MoS2 and its surface-enhanced Raman scattering 被引量:1
15
作者 Ya Deng minjiang chen +10 位作者 Jian Zhang Zihao Wang Wenbin Huang Yun Zhao Jean PierreNshimiyimana Xiao Hu Xiannian Chi Gu Hou ,Xueyao Zhang Yanjun Guo Lianfeng Sun 《Nano Research》 SCIE EI CAS CSCD 2016年第6期1682-1688,共7页
The size and density of Ag nanoparticles on n-layer MoS2 exhibit thickness- dependent behavior. The size and density of these particles increased and decreased, respectively, with increasing layer number (n) of n-la... The size and density of Ag nanoparticles on n-layer MoS2 exhibit thickness- dependent behavior. The size and density of these particles increased and decreased, respectively, with increasing layer number (n) of n-layer MoS2. Furthermore, the surface-enhanced Raman scattering (SERS) of Ag on this substrate was observed. The enhancement factor of this scattering varied with the thickness of MoS2. The mechanisms governing the aforementioned thickness dependences are proposed and discussed. 展开更多
关键词 MOS2 NANOPARTICLE thickness-dependent surface-enhanced Ramanscattering (SERS)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部